Skip to main
IPX

IperionX Ltd (IPX) Stock Forecast & Price Target

IperionX Ltd (IPX) Analyst Ratings

Based on 2 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

IperionX Ltd's positive outlook is supported by an increase in the EBITDA multiple from 7x to 8x for its 2029 projections, indicating a more favorable assessment of the company's profitability potential as it advances its operational capabilities. The company's innovative titanium technologies enable the production of sustainable, recyclable titanium products, positioning IperionX as a competitive player in the critical minerals market. Additionally, as IperionX ramps up its production and revenue, expectations for its valuation are anticipated to rise significantly, reflecting improved financial metrics and lower future dilution assumptions.

Bears say

IperionX Ltd faces substantial risks that may negatively impact its financial performance, primarily due to commodity price volatility affecting its titanium products. The company is susceptible to various operational challenges, including permitting or construction delays, production cost overruns, and difficulties in capturing market share. Furthermore, the potential for dilutive transactions and other unforeseen market events poses additional uncertainty for IperionX's growth prospects.

IperionX Ltd (IPX) has been analyzed by 2 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IperionX Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IperionX Ltd (IPX) Forecast

Analysts have given IperionX Ltd (IPX) a Strong Buy based on their latest research and market trends.

According to 2 analysts, IperionX Ltd (IPX) has a Strong Buy consensus rating as of Jan 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $51, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $51, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IperionX Ltd (IPX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.